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Tinnitus has been suggested to arise from neuronal hyperactivity in auditory areas of the
brain, and anti-epileptic drugs are sometimes used to provide relief from tinnitus. Recently,
the anti-epileptic properties of the cannabinoid drugs have gained increasing interest; how-
ever, the use of cannabinoids as a form of treatment for tinnitus is controversial. In this
study, we tested whether a combination of delta-9-tetrahydrocannabinol (delta-9-THC) and
cannabidiol (CBD), delivered in a 1:1 ratio, could affect tinnitus perception in a rat model
of acoustic trauma-induced tinnitus. Following sham treatment or acoustic trauma, the
animals were divided into the following groups: (1) sham (i.e., no acoustic trauma) with
vehicle treatment; (2) sham with drug treatment (i.e., delta-9-THC+CBD); (3) acoustic
trauma-exposed exhibiting tinnitus, with drug treatment; and (4) acoustic trauma-exposed
exhibiting no tinnitus, with drug treatment. The animals received either the vehicle or
the cannabinoid drugs every day, 30 min before the tinnitus behavioral testing. Acoustic
trauma caused a significant increase in the auditory brainstem response (ABR) thresh-
olds in the exposed animals, indicating hearing loss; however, there was a partial recovery
over 6 months. Acoustic trauma did not always result in tinnitus; however, among those
that did exhibit tinnitus, some of them had tinnitus at multiple frequencies while others
had it only at a single frequency. The cannabinoids significantly increased the number of
tinnitus animals in the exposed-tinnitus group, but not in the sham group. The results sug-
gest that cannabinoids may promote the development of tinnitus, especially when there
is pre-existing hearing damage.
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INTRODUCTION
Tinnitus is the perception and conscious awareness of sound that
is not physically present. These phantom sounds can be ringing or
buzzing noises or sometimes hissing, grinding, or roaring. Many
people experience tinnitus transiently at some time in their life,
but for chronic tinnitus sufferers, the condition can be frustrating
and debilitating. In severe cases, it can be extremely disturbing, and
even lead to suicide (1). Tinnitus affects 25% of the American pop-
ulation at some stage in their life, with 8% of people experiencing
persistent or chronic tinnitus (1). While the prevalence of chronic
tinnitus normally increases with age, it is alarming that an increas-
ing number of adolescents and young adults are experiencing it
due to risky music-listening behaviors, such as prolonged exposure
to high-volume music by using portable music players, or going
to excessively loud nightclubs or attending pop/rock concerts (2).
Tinnitus can be caused by exposure to loud noise, as well as
head and neck injuries; it can also develop as a result of inner ear
infection, drug toxicity (e.g., aminoglycoside antibiotics), or as a
result of aging (3, 4). Although the mechanisms underlying tinni-
tus are still not fully understood, the most likely cause of tinnitus
is changes in neural activity in the brain, which is supported by
both animal and human studies. In animals and humans with tin-
nitus, neurons in multiple areas of the brain become more active
and more neurons fire at the same time in order to compensate
for the hearing loss due to damage to the cochlear hair cells (5).
Based on the idea that tinnitus is generated by neuronal hyperac-
tivity in the brain, non-benzodiazepine anti-epileptic drugs, such
as carbamazepine, are often prescribed [see Ref. (6, 7) for reviews].
However, the preclinical evidence supporting the use of such drugs
is limited and contradictory, and the few clinical trials that have
been conducted have yielded inconsistent results [see Ref. (4, 6–8)
for reviews]. There is also evidence that cannabinoids can suppress
epileptiform and seizure activity in animals (9–11). However, there
has been no controlled study in humans of the effects of Cannabis
or cannabinoids on tinnitus itself.
One problem is that Cannabis contains over 400 different
chemicals, with 66 cannabinoid chemicals unique to the genus.
Studies in neuropharmacology have tended to focus on the key
psychoactive ingredient, delta-9-tetrahydrocannabinol (delta-9-
THC); however, there are many other cannabinoids in Cannabis
such as cannabinol and cannabidiol (CBD), and it is not always
obvious which cannabinoid is exerting the observed effects. In
addition to synthetic cannabinoid receptor agonists, such as dron-
abinol and nabilone, which are used clinically for the treatment
of nausea, vomiting, and wasting, natural Cannabis extracts such
as a 1:1 ratio of delta-9-THC and CBD (Sativex™), are used
for the treatment of spasticity and chronic pain in multiple
sclerosis (12).
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There are two classes of cannabinoid receptors, the CB1 and
CB2 receptors. The general consensus is that CB1 receptors are
expressed mainly in the CNS, while the CB2 receptors are local-
ized mainly to the immune system, peripheral nervous system,
testes, and retina [see Ref. (13) for a review]. The presynaptic
localization of many CB1 receptors and their inhibition of calcium
influx at presynaptic terminals may be the basis for any anticon-
vulsant effects, depending on the neurotransmitter being released.
Both Zheng et al. (14) and Tzounopoulos et al. (15) quantified
CB1 receptor expression in the cochlear nuclei. Tzounopoulos
et al. (15) observed CB1 receptors in the dorsal cochlear nucleus
(DCN) at the parallel fiber/cartwheel cell, parallel fiber/fusiform
cell synapses, and on the dendritic spines of cartwheel cells, using
electron microscopy. Furthermore, Zhao et al. (16) demonstrated
that both fusiform and cartwheel cells expressed diacylglycerol
(DAG) α and β, the two enzymes necessary for the production
of the endocannabinoid, 2-arachidonyl glycerol (2-AG). There-
fore, there is substantial evidence for an endocannabinoid system
within the DCN, which may be important for the development of
tinnitus.
Only two studies to date have investigated the relationship
between CB1 receptors in the CN and tinnitus. Zheng et al. (14)
studied the expression of CB1 receptors in the DCN and ventral
cochlear nucleus (VCN) of rats in which tinnitus had been induced
using salicylate injections. They found a significant decrease in the
number of neurons expressing CB1 receptors in the VCN com-
pared to control animals. In the only animal study of the effects
of cannabinoids on tinnitus itself, Zheng et al. (17) investigated
the effects of two CB1 receptor agonists, WIN55,212-2 and CP-
55940, on tinnitus induced by salicylate injections in rats. Neither
WIN55,212-2 nor CP55,940 significantly reduced the conditioned
behavior associated with tinnitus perception. However, 3 mg/kg
WIN55,212-2 and 0.3 mg/kg CP-55940 did significantly increase
this behavior in normal control animals, suggesting that these
cannabinoids might induce tinnitus-related behavior.
Given the lack of evidence relating to the effects of Cannabis on
tinnitus in humans and the recent data supporting the existence of
an endocannabinoid system in the cochlear nucleus, the aim of this
study was to further investigate the effects of cannabinoid drugs
on acoustic trauma-induced tinnitus, using a 1:1 ratio of delta-
9-THC and CBD, which is equivalent to Sativex™ used in the
treatment of spasticity and chronic pain in multiple sclerosis (12).
MATERIALS AND METHODS
ANIMALS
Fifty male Wistar rats (300–350 g at the beginning of the experi-
ments) were used in this study. The animals were housed in groups
of 2–3 per cage under a 12:12 h light:dark cycle at 22°C and were
water deprived throughout the tinnitus behavioral testing. All pro-
cedures were approved by the University of Otago Committee on
Ethics in the Care and Use of Laboratory Animals.
DRUGS
Delta-9-THC and CBD were purchased from THC Pharm GmbH
(Frankfurt, Germany). The drugs were dissolved in Tween 80 and
Ethanol (1:1) to make a 50 mg/ml stock solution of the mixture
of delta-9-THC and CBD. A working solution containing 1 mg/ml
of delta-9-THC and 1 mg/ml of CBD was made freshly every day
by diluting the stock solution with saline. This 1:1 ratio of delta-
9-THC and CBD was designed to approximate the cannabinoid
drug, Sativex™, which is used in the treatment of spasticity and
chronic pain in multiple sclerosis in humans (12). Multiple doses
of this mixture were not tested simply due to the expense of the
drugs.
EXPERIMENTAL DESIGN
The animals were randomly divided into sham (n= 20) and
exposed (n= 30) groups and exposed to either the acoustic trauma
or sham procedure. One month later, the animals were tested
for the behavioral signs of tinnitus using a conditioned lick
suppression paradigm. Following the confirmation of tinnitus,
the acoustic trauma-exposed animals were further divided into
exposed-tinnitus and exposed-no tinnitus groups. The effects of
cannabinoids on tinnitus were investigated by administering either
vehicle or delta-9-THC (1.5 mg/kg, s.c.) and CBD (1.5 mg/kg, s.c.)
every day, 30 min before tinnitus testing, throughout the tinnitus
testing period for a total of 27 days. These doses were the maximum
doses that could be used without causing sedation in rats, during a
pilot study. The animals were then given a 2-week washout period
for the drugs to be eliminated before being tested again for the
behavioral signs of tinnitus.
ACOUSTIC TRAUMA TO INDUCE TINNITUS
The animals were exposed to unilateral acoustic trauma using the
methods described in our previous publications (18–22). Briefly,
the animals were anesthetized with a fentanyl (0.2 mg/kg, s.c.) and
medetomidine hydrochloride (0.5 mg/kg, s.c.) mixture and placed
inside a sound attenuation chamber. A 16 kHz pure tone with an
intensity of 115 dB, generated by a NI 4461 Dynamic Signal Acqui-
sition and Generation system (National Instruments New Zealand
Ltd.), was delivered to one of the ears for 1 h through a closed field
magnetic speaker with a tapered tip (Tucker-Davis Technologies).
The unexposed ear was blocked with cone-shaped foam and taped
against the foam surface inside the sound attenuation chamber.
The sham animals received the same anesthetics and were kept
under anesthesia for the same duration as the acoustic trauma
animals, but without acoustic trauma exposure.
HEARING LEVELS
Hearing levels were measured using auditory brainstem response
(ABR) thresholds in both the ears of exposed and sham animals
before the acoustic trauma, in both the ears of the exposed animals
immediately after the acoustic trauma, in the ipsilateral ear of all
exposed animals and in both ears of selected sham animals at the
conclusion of the study. Briefly, the animals were anesthetized as
previously described and acoustic stimuli were presented directly
to the entrance of the ear canal using the same set-up as for the
acoustic trauma. Stainless steel needle electrodes were placed s.c.
at the vertex and over the bullae with a reference electrode at the
occiput. ABR thresholds were tested for tone bursts presented at
a rate of 50/s. Tone bursts (2 ms rise/decay, 1 ms plateau) were
presented in a decreasing intensity series, beginning with levels
that elicited distinct evoked potentials. Hearing thresholds were
indicated by the lowest intensity that produced visually distinct
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potentials, progressing in 20-, 10-, and 5-dB steps for 8, 16, 20, and
32 kHz stimuli (18–22).
BEHAVIORAL ASSESSMENT OF TINNITUS
The presence of tinnitus was assessed using a conditioned lick
suppression paradigm as described in our previous publications
(18–22). Briefly, the animals were water deprived and allowed to
drink inside an operant conditioning test chamber (ENV-007, Med
Associates Inc.) by licking through a sipper tube. The number of
licks was sensed by an infrared photobeam and recorded on a com-
puter. The animal’s free-feeding weight was taken as a baseline and
the body weight was monitored every day before the behavioral
testing. If a rat made less than 1000 licks during any given session,
extra water was provided for 30 min in its home cage after the test-
ing session and if there was a weight loss of 10% of their baseline
body weight, extra water was provided outside the testing period.
This water deprivation schedule typically kept their body weight
at 90–95% of their baseline body weight and motivated the rats
to produce reliable licks (1500–3500 licks per session) during the
tinnitus testing sessions.
The conditioned lick suppression paradigm consisted of 15 min
of testing every day and the animals went through three phases: the
acclimation phase, the Pavlovian conditioned suppression training
phase, and the frequency discrimination phase. During the accli-
mation phase, a broadband noise (BBN, 60 dB SPL) was presented
throughout the 15 min session except at 10 random intervals,
at which point 15 s acoustic stimuli presentations were inserted.
Two of the 10 presentations were always speaker off periods (i.e.,
silence) and the remaining 8 were either BBN, 20 kHz tones or
32 kHz tones at 4 different intensity levels (30, 40, 50, and 70 dB
SPL for BBN; 70, 80, 90, and 100 dB SPL for 20 and 32 kHz) in a
random order with each stimulus repeated twice within each ses-
sion. The type of stimulus was varied randomly between sessions,
but remained constant within a session, and the stimulus presen-
tations did not occur within 1 min of one another, or within 1 min
of the beginning or the end of the session. The animals had three
sessions of acclimation for each type of stimulus.
Following acclimation, each animal received conditioned sup-
pression training in which a 3 s foot shock (0.35 mA) was presented
at the end of each speaker off (silence) period. Over a few sessions,
the animals learned the association between the speaker off and
the foot shock and reacted to the speaker off by stopping licking.
The number of licks in the 15 s period preceding the stimulus pre-
sentation and the number of licks during the 15 s of the stimulus
presentation were recorded. The lick suppression was measured
by comparing the number of licks in these two periods, i.e., the
suppression ratio (SR):
SR = B
A + B
whereA is the number of licks in the preceding period and B is the
number of licks in the stimulus presentation period. If a rat did
not make any licks during the 15 s period preceding the stimulus
presentation, the corresponding SR for this particular period was
excluded.
Once the lick suppression was established (SR< 0.2), the rats
were subjected to the frequency discrimination test, during which
the acoustic stimuli were presented in the same manner as in the
acclimation and the suppression training and each stimulus was
tested for 5–6 sessions, with one session per day. Foot shock was
delivered only if the SR for the speaker off period was >0.2. Dur-
ing the drug treatment, we allowed nine sessions (three sessions
each frequency) for the animals to establish new associations with
changes in their tinnitus status if there were any and data collected
from the first nine sessions of drug treatment were discarded.
During the first few days, more foot shocks were triggered by the
animals, which suggested the re-establishment of conditioned sup-
pression. Furthermore, animals were tested every day for a further
18 sessions (six sessions for each stimulus) during the drug treat-
ment period. This ensured that the animals had enough time to
be reconditioned and to produce reliable responses.
If a rat did not have tinnitus, it would associate the silence
period with the foot shock and the presentation of the stim-
uli had no meaning to it, therefore, its drinking activity would
not be affected during the acoustic stimuli presentation periods.
However, if a rat had tinnitus, it would hear its tinnitus dur-
ing the silence period and associate its tinnitus, instead of the
silence, with the foot shock. Therefore, a stimulus with sensory
features resembling tinnitus during the testing session should act
as a conditioned stimulus and produce greater suppression dur-
ing the stimulus presentation period. Using this method, we have
successfully induced and assessed tinnitus in rats in our labora-
tory and confirmed that the duration of tinnitus can last as long
as 10 months after the acoustic trauma exposure, although the
hearing loss is temporary (18–21).
CRITERIA TO IDENTIFY TINNITUS ANIMALS
Following the first tinnitus test and before the drug treatment,
the frequency discrimination curve from each of the acoustic
trauma-exposed animals was constructed for BBN, 20 and 32 kHz,
respectively, and compared with the mean frequency discrimina-
tion curve from the sham group. The exposed animals with lower
SRs that were clearly separated from the sham animals at two
or more intensity levels measured were considered to have tin-
nitus. This procedure inevitably meant that the sample sizes for
the different groups were unequal, which is potentially a prob-
lem for the statistical analysis of repeated measures data, e.g.,
using analysis of variance (ANOVA). For this reason, we did not
employ repeated measures ANOVAs but rather, a linear mixed
model (LMM) analysis with a restricted maximum likelihood pro-
cedure, because it does not assume a balanced design and also
addresses the correlation structure of the repeated measures data
(see below) (23–26).
STATISTICAL ANALYSIS
All data were tested for normality and homogeneity of variance,
and a LMM analysis was undertaken using SPSS 22. Where these
assumptions were violated, the data were square root transformed
and re-tested. The SR data for tinnitus assessment were analyzed
with a LMM analysis using a restricted maximum likelihood pro-
cedure (18–20, 23–25). LMM analyses were used in preference to
repeated measures ANOVAs because of the problems caused by
extensive autocorrelation in repeated measures data; LMM analy-
ses model the covariance structure of the repeated measures data
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in order to address this problem (23–25). The data were analyzed
with group (sham-vehicle, sham-drug, exposed-no tinnitus-drug,
or exposed-tinnitus-drug) as a fixed factor and intensity as a
repeated measure. Akaike’s Information Criterion (AIC) was used
to determine the most appropriate covariance structure. Where
appropriate, Bonferroni’s corrected post hoc tests were used to
make pairwise comparisons. Results were considered significant
if P ≤ 0.05. The number of animals with or without behavioral
evidence of tinnitus was compared before, during, and after the
drug administration using Chi-square tests.
RESULTS
In general, acoustic trauma resulted in a frequency-dependent
increase in the ABR thresholds in the ipsilateral ear, which was sim-
ilar for the tinnitus and no-tinnitus groups and which recovered
partially over 6 months post-exposure. Acoustic trauma caused
a significant increase in the ABR thresholds in the exposed ani-
mals as indicated by a significant group effect (F3, 202.630= 2.874,
P = 0.037) (Figures 1A,B). Post hoc tests revealed that there was
no difference in the degree of ABR threshold elevation between
the exposed-no tinnitus animals and the exposed-tinnitus ani-
mals (P = 1.000). The increase in the ABR thresholds was specif-
ically in the ear ipsilateral to the acoustic trauma exposure and
across all the frequencies tested, since there was a significant
side effect (F1, 240.459= 189.928, P = 0.0001) and a significant
frequency effect (F3, 517.500= 9.861, P = 0.0001). Moreover, the
increase was also frequency-dependent as there were signifi-
cant differences between all of the frequencies tested with larger
increases at higher frequencies (8 vs 16 kHz, P = 0.29; 8 vs 20 kHz,
P = 0.0001; 8 vs 32 kHz, P = 0.0001; 16 vs 20 kHz, P = 0.0001; 16
vs 32 kHz,P = 0.030; and 20 vs 32 kHz,P = 0.036). However, a sig-
nificant side× frequency interaction indicated that the frequency-
dependent increase in ABR threshold was specifically due to the
ipsilateral ear (Figures 1A,B, middle panel). An overall significant
time effect (F2, 268.563= 245.389, P = 0.0001) and a side× time
interaction (F2, 253.408= 187.320, P = 0.0001) also confirmed an
ipsilateral increase in ABR thresholds following acoustic trauma.
Although there was a considerable recovery of the ABR thresholds
FIGURE 1 | ABR thresholds for the ipsilateral (A) and contralateral (B) ears of sham-vehicle, sham-acoustic, exposed-no tinnitus-drug, and
exposed-tinnitus-drug animals pre-exposure, immediately post-exposure, and 6months post-exposure, as a function of stimulus intensity in dB SPL
and frequency in kHz. Data are presented as means± 1 SE.
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at 6 months following acoustic trauma (Figures 1A,B, right panel),
pairwise comparisons revealed a significant difference between
the ABR thresholds before and immediately after acoustic trauma
(P = 0.0001), immediately and at 6 months after acoustic trauma
(P = 0.0001) as well as before and at 6 months after acoustic
trauma (P = 0.0001).
At 1 month following the acoustic trauma, the animals under-
went behavioral testing for the presence of tinnitus. After the
completion of the test, the sham animals were randomly divided
into two groups, vehicle and drug groups, and two mean frequency
discrimination curves were constructed. A frequency discrimi-
nation curve was constructed for each of the exposed animals
and compared with the two sham mean discrimination curves.
The frequency discrimination curve showed a general increase in
SR value with the increase in testing stimulus intensity, which
reflects the increase in the discriminative nature between the test-
ing stimulus and the conditioned stimulus (e.g., silence), i.e.,
the louder the testing stimulus is, the easier it is able to be dis-
tinguished from silence, therefore, the less suppression and the
higher the SR value. Exposed animals were selected to become
part of the exposed-tinnitus-drug group if two or more points
on their frequency discrimination curve were clearly below the
mean sham discrimination curves. The rest of the exposed ani-
mals were grouped as an exposed-no tinnitus-drug group. Based
on this criterion, 6 animals were considered to experience tin-
nitus for BBN stimuli, 8 for 20 kHz stimuli, and 10 for 32 kHz
stimuli. Among these animals, some of them had tinnitus at mul-
tiple frequencies while others had it only at a single frequency.
Therefore, there were a total of 14 rats considered to have tinnitus.
When the mean frequency discrimination curves were compared
between these four groups, there was a significant group effect
for BBN (F3, 46.485= 5.155, P = 0.004), 20 kHz (F2, 46.550= 4.386,
P = 0.008) and 32 kHz (F2, 46.592= 9.660, P = 0.000) stimuli
(Figure 2, left panel). Post hoc tests revealed a significant differ-
ence between the exposed-tinnitus-drug group and exposed-no
tinnitus-drug group for all three stimuli tested (BBN, P = 0.02;
20 kHz, P = 0.01; 32 kHz, P = 0.0001), between the exposed-
tinnitus-drug group and sham-drug group for 20 kHz stimuli
(P = 0.034) and between the exposed-tinnitus-drug group and
sham-vehicle group for 32 kHz stimuli (P = 0.039).
In order to test whether the combination of THC and CBD
could affect the perception of tinnitus in rats, the drugs were
injected every day, 30 min before the tinnitus behavioral testing.
During the administration of THC and CBD, there was a notice-
able number of animals from the exposed-no tinnitus-drug group
exhibiting greater lick suppression behavior in reaction to the
presentation of the stimuli (Figure 2, middle panel). When the
mean frequency discrimination curves from the four groups were
compared, there was a significant group effect for 20 kHz stimuli
(F3, 45.006= 6.346, P = 0.001) and a significant group × intensity
interaction for 32 kHz (F12, 71.752= 1.902, P = 0.048), but there
was no group effect for BBN. Post hoc tests revealed that when
FIGURE 2 | Frequency discrimination curves for sham-vehicle (n=10), sham-acoustic trauma (n=10), exposed-no tinnitus-drug (n=24, 22 and 20),
and exposed-tinnitus-drug animals (n=6, 8, and 10) in response to acoustic stimuli for BBN, 20 and 32kHz tones before, during and after the drug
administration. Data are presented as means±1 SE.
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presented with 20 kHz tones, the mean frequency discrimination
curve for the exposed-no tinnitus-drug group was significantly
shifted downward and there was a significant difference between
the exposed-no tinnitus-drug and sham-drug groups (P = 0.009).
Moreover, the difference between the exposed-no tinnitus-drug
and exposed-tinnitus-drug groups had disappeared (P = 1.000),
which suggests that some animals from the exposed-no tinnitus-
drug group had developed tinnitus while receiving THC and CBD.
Although there was no significant group effect when 32 kHz stim-
uli were presented, the significant group × intensity interaction
indicated that animals from different groups reacted differently
to different intensities of the 32 kHz tones. A close inspection
of the frequency discrimination curves (Figure 2, middle panel,
third row) revealed that both the exposed-no tinnitus-drug and
exposed-tinnitus-drug groups produced more lick suppression
when the 32 kHz tone was presented at 100 dB SPL.
To find out whether THC and CBD would have any long-lasting
effects on the animals’ tinnitus-like behavior, the animals were
given a 2-week washout period during which the drug admin-
istration was stopped and the animals had free access to water
and food. The tinnitus testing resumed after the washout period
and there was only a significant group effect for 32 kHz tones
(F3, 48.581= 3.870, P = 0.015), but not BBN or 20 kHz tones. This
significant group effect was due to the difference between the
exposed-tinnitus-drug and sham-drug groups (P = 0.011).
In addition, the proportion of acoustic trauma-exposed ani-
mals that had behavioral signs of tinnitus was compared before,
during, and after the drug administration for BBN, 20 or 32 kHz
stimuli presentations (Figure 3). Although more animals dis-
played behavioral evidence of tinnitus during the administration
of THC and CBD for all three stimuli tested, a significant increase
in the number of tinnitus animals was evident only for 20 kHz
stimuli (χ2= 10.94, df= 2, P = 0.004). There was no difference
in the number of tinnitus animals before and after the drug
administration.
DISCUSSION
Our results showed that following acoustic trauma, only a propor-
tion of animals developed tinnitus and the rest did not. However,
the combination of THC and CBD reversibly increased the num-
ber of tinnitus animals in the exposed, but not the sham groups,
which suggests that THC and CBD may promote the perception
of tinnitus if there is pre-existing hearing damage.
It has been shown that not every animal exposed to acoustic
trauma develops tinnitus, with the reported tinnitus-induction
rate varying from 30 to 80% [see Ref. (27) for a review]. Whether
an animal develops tinnitus or not seems to be not directly corre-
lated with the degree of hearing loss either immediately after the
acoustic trauma exposure or a few months later [see Ref. (27) for
a review]. In the present study, all of our rats exhibited elevated
ABR thresholds across a range of frequencies immediately after the
acoustic trauma. It has been reported that exposure to loud tones at
10 kHz resulted in an immediate hearing loss across a wide range
of frequencies both below and higher (i.e., 6–24 kHz) than the
exposed frequency using compound action potential audiograms
(28), which is in agreement with our observations. However, it
is believed that the maximum hearing loss following exposure to
FIGURE 3 | Number of tinnitus and no tinnitus animals following
acoustic trauma before, during, and after the drug administration.
loud tones usually occurred at half an octave above the exposed fre-
quency (29). However, in the present study the maximum hearing
loss was at 32 kHz, which is a full octave above the exposed fre-
quency of 16 kHz. This might be due to the presence of harmonic
distortion of the 16 kHz tone. However, this harmonic tone at
32 kHz was measured 30 dB below the 16 kHz tones, which should
be less likely to cause greater hearing loss, although unexpected
damage could still occur due to the increased susceptibility of
hair cells in the higher frequency regions to free radicals (30). It
might also be necessary to measure hearing loss at 24 kHz follow-
ing exposure to 16 kHz tones in order to confirm whether a greater
hearing loss would occur at half an octave above the exposed fre-
quency. Nevertheless, the hearing loss recovered substantially at
6 months following exposure. Although the ABR thresholds in the
exposed animals did not completely return to the pre-exposure
level, they were not different from the sham animals tested in par-
allel. Therefore, the slightly elevated ABR thresholds at the end
of the experiment might have been due to age-related changes,
although it seems less likely to be the case given that the age of our
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rats (9–10 months old) was a few months younger than the age
of the Wistar rats (12–14 months old) showing age-related hear-
ing loss (31). Nevertheless, the fact that our exposed animals had
similar degrees of acute hearing loss and recovery and only some
of them developed tinnitus, suggests that tinnitus development
might not be reflected by the gross changes in ABR thresholds.
Schaette and McAlpine (32) reported that human tinnitus sub-
jects could have a normal audiogram and a normal amplitude
of the centrally generated ABR wave V, but a significantly reduced
amplitude of the auditory nerve-generated ABR wave I, which sug-
gests a “hidden hearing loss” in these tinnitus patients. In addition,
the relationship between altered ABR waveforms and tinnitus has
also been studied in animals models (33, 34), with an increase in
early ABR wave amplitude up to N3 (33) and both increases (33)
and decreases (34) in latencies reported. In this study, the ABR was
not measured either at 1 month post-exposure or during the drug
treatment, when changes in the animal’s tinnitus status occurred.
Therefore, it is impossible to make valid correlations using the cur-
rently available ABR results. Future studies are needed to further
analyze changes in the different components of the ABR waves in
animals with tinnitus.
Among the animals that exhibited behavioral evidence of tinni-
tus, i.e., the downward shift of the frequency discrimination curve,
tinnitus manifested at different frequencies, with some animals
experiencing it at multiple frequencies and within the same animal,
there were fluctuations of tinnitus-like behavior in response to
specific frequencies at different time points following the acoustic
trauma. These observations are generally in agreement with our
previous publications and those of others (35–38). Following the
administration of THC and CBD, exposed-no tinnitus-animals
showed increased suppression during the drug treatment for the
20 kHz stimulus and to a lesser extent, for the 32 kHz stimulus
and a separate analysis looking at the proportion of animals expe-
riencing tinnitus showed that there were more tinnitus animals
during the drug treatment in response to the 20 kHz stimulus.
Taken together, the results indicated that more animals shift from
no-tinnitus to tinnitus status in the exposed-no tinnitus group,
which suggests that THC and CBD may promote or enhance the
perception of tinnitus in animals. However, following a 2-week
washout period, this effect disappeared for 20 kHz stimuli. In addi-
tion, animals in the sham-drug group showed an up-shift in the
suppression curve for both 20 and 32 kHz stimuli. The explanation
for these effects is unknown; however, because delta-9-THC has a
long half-life and is sequestered in fat (39), it is possible that this
is due to some kind of delayed therapeutic effect. Perhaps another
washout test at a later time point could provide more conclusive
results.
Due to the fact that the number of animals exhibiting behav-
ioral signs of tinnitus was similar before and after drug treatment,
but significantly increased during drug treatment, this increase
in the number of tinnitus animals cannot be explained simply
by tinnitus fluctuation. In addition, we also observed greater lick
suppression in response to the BBN, which has been suggested
to be due to hearing loss (37). In this study, this increase in sup-
pression in response to the BBN was only evident at 1 month
post-exposure, but not at later time points, which might reflect
temporary hearing loss following acoustic trauma. However, the
ABR was not measured at 1 month post-exposure in this study;
therefore, a definitive conclusion could not be drawn.
It has been shown that acoustic trauma results in neuronal
hyperactivity in different areas of the brain including the cochlear
nucleus, the inferior colliculus, the medial geniculate body, and the
auditory cortex (5, 40–44). The hyperactivity, at least in the DCN,
has been attributed to a decrease of GABAergic inhibition (45) and
the burst firing of the fusiform cells (46). One type of GABAer-
gic interneuron in the DCN is the cartwheel cells, which strongly
inhibit fusiform cells through feed-forward inhibition (47). Presy-
naptic CB1 receptors have been found at the terminals of parallel
fibers synapsing with the cartwheel cells and activating the presy-
naptic CB1 receptors, as a result of either the sustained firing of
cartwheel cells or the application of a CB1 receptor agonist, sig-
nificantly reducing the synaptic strength (15, 48). Therefore, it is
conceivable that the activation of CB1 receptors on presynaptic ter-
minals resulted in a decrease in GABA release from the cartwheel
cells, which in turn resulted in a reduction in inhibition of the
fusiform cells. It is interesting that this effect was only observed
in animals that had been exposed to acoustic trauma, but not
in sham animals. It has been reported that somatosensory input
transmitted by parallel fibers produced a suppression-dominant
effect on auditory processes in normal animals, but this effect
was shifted to enhancement in exposed-tinnitus animals and to a
much less extent in exposed-no tinnitus animals (49). Although
this shift to enhancement is less pronounced in exposed no tinnitus
animals, the cannabinoids might be able to increase this enhance-
ment effect to the level comparable to that in exposed tinnitus
animals. However, cannabinoids might not be able to shift the
suppression-dominant effect to enhancement in sham animals.
Having said this, it must be appreciated that the drug adminis-
tration in this study was systemic, and therefore, the actions of
THC and CBD cannot be attributed solely to the cochlear nucleus
or even the central auditory system; in fact, the effects of these
cannabinoids on any area of the CNS, including the limbic system
that projects to the central auditory system, could conceivably have
contributed to the observed effects on tinnitus-related behavior.
The other issue that must be noted is that although delta-9-THC
is a partial agonist at CB1 receptors, CBD can act as a partial
CB1 antagonist (50), and it is impossible to know the net effect
of these two drugs, even in the cochlear nucleus. Furthermore,
previous studies have demonstrated that acute and chronic dose
regimens with cannabinoid drugs can have quite different effects.
For example, Okine et al. (51) reported that chronic pre-treatment
with URB597, and inhibitor of fatty acid amide hydrolase, a key
enzyme in the metabolism of the endocannabinoid, anandamide,
had no effect on inflammatory pain behavior in rats, whereas a sin-
gle dose significantly reduced it. It is therefore quite conceivable
that we might have observed different results with acute dosing of
delta-9-THC/CBD.
In addition, endocannabinoids in the central nucleus of the
amygdala have been implicated in short-term adaptation of
the conditioned fear response, and the CB1 receptor antagonist
AM251 increased the fear response (52). Because systemic injec-
tions were used to deliver the drugs in this study, it could be argued
that changes in the frequency discrimination curve might not
reflect the perception of tinnitus but rather changes in the fear
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response through the drugs’ effects on the amygdala. However, if
this was the case, cannabinoids would facilitate the adaptation of
the conditioned fear response and result in an upward shift of the
curve rather than the downward shift observed in the exposed no
tinnitus animals. A close inspection of the curves did reveal a slight
upward shift of the curve in the sham-drug animals in response to
20 kHz tones during the drug administration and in response to 20
and 32 kHz tones after drug administration, which suggests that
adaptation of the conditioned fear response might have occurred
in our animals. However, this adaptation was not enough to affect
the greater lick suppression in animals with tinnitus.
Although Cannabis is used by some tinnitus sufferers to relieve
their condition, our results, consistent with our previous study
using the salicylate model (17), suggest that cannabinoids, such
as delta-9-THC and CBD, may actually aggravate tinnitus (53).
This might be predicted from the work of Zhao et al. (16), which
suggested that the net effect of activation of CB1 receptors in the
DCN might be to increase the excitation of fusiform cells, thus
exacerbating neuronal hyperactivity.
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